Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK and Theravance file COPD drug

July 16, 2012
Research and Development, Sales and Marketing EMA, GSK, Relovair, Revlar, Spiriva, Theravance

GlaxoSmithKline and US biopharma firm Theravance have submitted their investigational chronic obstructive pulmonary disease (COPD) drug to regulators in Europe …

News
GSK image

GSK launches Olympics drug test adverts

July 16, 2012
Medical Communications, Sales and Marketing GSK, London 2012, Olympics, doping

GlaxoSmithKline has launched a UK advertising campaign to celebrate the role anti-doping science will play in keeping the Games as …

News

AZ sets up Alzheimer’s research collaborative

July 13, 2012
Research and Development Alzheimer's, AstraZeneca, neuroscience

AstraZeneca and Dr Steven Paul of Weill Cornell Medical College have unveiled a new research alliance that brings four leading …

News
astrazeneca image

AstraZeneca buys neuroscience molecules

July 13, 2012
Research and Development Alzheimer's, AstraZeneca, neuroscience

AstraZeneca is to acquire a portfolio of neuroscience assets from Link Medicine, a private US pharma firm.The deal is the …

News

Social care plan criticised

July 13, 2012
Sales and Marketing Kings Fund, NHS, king's fund, reform, social care

A leading health think-tank has criticised what it calls the ‘financial vacuum’ at the heart of the government’s plans for …

News

Success Factors in Value Communication Design – Start with the Key Message

July 12, 2012
Sales and Marketing interactive apps, value, value communication design

This is Part 1 to the ‘Success Factors in Value Communication Design’ series; a set of articles that examine and explain the …

Feature
Thought Leadership

Success Factors in Value Communication Design – Introduction

July 12, 2012
Sales and Marketing interactive apps, sales, value, value communications

This is the introductory article to the ‘Success Factors in Value Communication Design’ series; a set of articles that examine and explain …

Feature
Thought Leadership
rob_gallo_takeda

Takeda appoints new head of Corporate Communications, Europe and Canada

July 12, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, communications

Takeda Pharmaceuticals has appointed Rob Gallo as head of Corporate Communications, Europe and Canada. Since 2010 Gallo has been the …

Appointment
drbarbarahakin

NHS appoints first CSS managing directors

July 12, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hakin, NHS

The first round of appointments to commissioning support service (CSS) managing director posts has been made by the NHS Commissioning …

Appointment
Actelion image

Jobs under threat in Actelion cost saving

July 12, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Actelion, R&D, Tracleer, cuts

Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …

News

Amakem appoints new head of CMC and Operations

July 12, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing

Belgium-based Amakem NV has announced the appointment of Maarten van Geffen as head of CMC and Operations. The kinase platform …

Appointment
Health Foundation image

Fishburn Hedges hired to review Health Foundation’s profile

July 12, 2012
Medical Communications Fishburn Hedges, Health Foundation, NHS

PR firm Fishburn Hedges has been appointed by the Health Foundation to review and refresh the charity’s corporate communications.  The …

News

Boehringer collaborates for online ‘beyond pill’ plan

July 11, 2012
Medical Communications Boehringer, diabetes, digital, healthrageous

Boehringer Ingelheim is collaborating with US digital health specialist Healthrageous on a scheme to help type II diabetes sufferers manage …

News
Janssen image

Janssen buys into regenerative diabetes portfolio

July 11, 2012
Research and Development, Sales and Marketing CureBeta, Evotec, Janssen, diabetes

Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …

News

Blow for BioInvent as vascular treatment fails

July 11, 2012
Research and Development, Sales and Marketing BI-204, BioInvent, LDL, Sweden

Swedish biotech company BioInvent has suffered a new blow with the failure of its lead pipeline candidate.  The company’s share …

News

Significant reorganisation for Chelsea Therapeutics

July 11, 2012
Research and Development, Sales and Marketing Chelsea Therapeutics, Northera, biopharma, biotech

Biopharma development firm Chelsea Therapeutics has announced a major corporate reorganisation. The move includes a significant reduction in headcount, the …

News

New chief executive for Daiichi Sankyo Europe

July 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daiichi Sankyo

Jan Van Ruymbeke has been appointed as the new chief executive of Daiichi Sankyo Europe from October. Van Ruymbeke, from Belgium, …

Appointment

R&D, East & West: Lilly invests in its global research network

July 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly

Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …

Feature

Negative overtures persuade Sanofi to withdraw drug filing

July 10, 2012
Sales and Marketing EMA, Mulsevo, Sanofi, blood clots, withdrawal

Sanofi has withdrawn its marketing applications worldwide for its drug Mulsevo. Designed to stop blood clots in cancer patients receiving …

News
Xarelto image

Priority review for Xarelto’s new indications

July 10, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Eliquis, FDA, Janssen, Pradaxa, Xarelto

Xarelto is to be given a FDA fast-track review for a range of anti-blood clotting uses. Xarelto (rivaroxaban) gained its …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026